12.96

12.96 (-0.82%)

As of Mar 04, 2024

Greenwich LifeSciences, Inc. [GLSI]

Source: 

Company Overview

Greenwich Lifesciences, Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrencesin patients who have previously undergone surgery.

CountryUS
Headquartersstaffordtexas
Phone Number(203) 434-3290
Industry
CEOSnehal Patel
Websitegreenwichlifesciences.com

Recent Stories